Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

July 01, 1991; Volume 40,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Ahluwalia, G S

    1. You have access
      Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
      N R Hartman, G S Ahluwalia, D A Cooney, H Mitsuya, S Kageyama, A Fridland, S Broder and D G Johns
      Molecular Pharmacology July 1991, 40 (1) 118-124;
  2. Azuma, M

    1. You have access
      Tetrodotoxin-insensitive Na+ channel activator palytoxin inhibits tyrosine uptake into cultured bovine adrenal chromaffin cells.
      K Morita, K Teraoka, M Azuma, M Oka and S Hamano
      Molecular Pharmacology July 1991, 40 (1) 112-117;

B

  1. Baden, H A

    1. You have access
      Purification, immunochemical characterization, and immunohistochemical localization of rat hepatic aryl sulfotransferase IV.
      M W Duffel, T P Binder, L Hosie, H A Baden, J A Sanders, S A Knapp and J Baron
      Molecular Pharmacology July 1991, 40 (1) 36-44;
  2. Baron, J

    1. You have access
      Purification, immunochemical characterization, and immunohistochemical localization of rat hepatic aryl sulfotransferase IV.
      M W Duffel, T P Binder, L Hosie, H A Baden, J A Sanders, S A Knapp and J Baron
      Molecular Pharmacology July 1991, 40 (1) 36-44;
  3. Beaune, P H

    1. You have access
      Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.
      P K Srivastava, C H Yun, P H Beaune, C Ged and F P Guengerich
      Molecular Pharmacology July 1991, 40 (1) 69-79;
  4. Binder, T P

    1. You have access
      Purification, immunochemical characterization, and immunohistochemical localization of rat hepatic aryl sulfotransferase IV.
      M W Duffel, T P Binder, L Hosie, H A Baden, J A Sanders, S A Knapp and J Baron
      Molecular Pharmacology July 1991, 40 (1) 36-44;
  5. Broder, S

    1. You have access
      Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
      N R Hartman, G S Ahluwalia, D A Cooney, H Mitsuya, S Kageyama, A Fridland, S Broder and D G Johns
      Molecular Pharmacology July 1991, 40 (1) 118-124;
  6. Bruinvels, A

    1. You have access
      Three-dimensional models of neurotransmitter G-binding protein-coupled receptors.
      M F Hibert, S Trumpp-Kallmeyer, A Bruinvels and J Hoflack
      Molecular Pharmacology July 1991, 40 (1) 8-15;

C

  1. Charleson, P

    1. You have access
      5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;
  2. Clifford, D B

    1. You have access
      Effects of bromowillardiine and willardiine on non-N-methyl-D-aspartate receptors in postnatal rat hippocampal neurons.
      C F Zorumski, L L Thio and D B Clifford
      Molecular Pharmacology July 1991, 40 (1) 45-51;
  3. Coffman, B

    1. You have access
      Purification and properties of a rat liver phenobarbital-inducible 4-hydroxybiphenyl UDP-glucuronosyltransferase.
      P Styczynski, M Green, J Puig, B Coffman and T Tephly
      Molecular Pharmacology July 1991, 40 (1) 80-84;
  4. Coon, M J

    1. You have access
      Differences in the developmental expression of rabbit cytochromes P-450 2E1 and 2E2.
      H M Peng, T D Porter, X X Ding and M J Coon
      Molecular Pharmacology July 1991, 40 (1) 58-62;
  5. Cooney, D A

    1. You have access
      Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
      N R Hartman, G S Ahluwalia, D A Cooney, H Mitsuya, S Kageyama, A Fridland, S Broder and D G Johns
      Molecular Pharmacology July 1991, 40 (1) 118-124;
  6. Cooper, C L

    1. You have access
      Solubilization of a guanine nucleotide-sensitive form of the P2Y-purinergic receptor.
      R A Jeffs, C L Cooper and T K Harden
      Molecular Pharmacology July 1991, 40 (1) 85-92;

D

  1. Ding, X X

    1. You have access
      Differences in the developmental expression of rabbit cytochromes P-450 2E1 and 2E2.
      H M Peng, T D Porter, X X Ding and M J Coon
      Molecular Pharmacology July 1991, 40 (1) 58-62;
  2. Dissanayake, V U

    1. You have access
      Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography.
      V U Dissanayake, J Hughes and J C Hunter
      Molecular Pharmacology July 1991, 40 (1) 93-100;
  3. Duffel, M W

    1. You have access
      Purification, immunochemical characterization, and immunohistochemical localization of rat hepatic aryl sulfotransferase IV.
      M W Duffel, T P Binder, L Hosie, H A Baden, J A Sanders, S A Knapp and J Baron
      Molecular Pharmacology July 1991, 40 (1) 36-44;

E

  1. Eichelbaum, M

    1. You have access
      Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanism.
      H K Kroemer, C Fischer, C O Meese and M Eichelbaum
      Molecular Pharmacology July 1991, 40 (1) 135-142;
  2. Evans, J F

    1. You have access
      5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;

F

  1. Fischer, C

    1. You have access
      Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanism.
      H K Kroemer, C Fischer, C O Meese and M Eichelbaum
      Molecular Pharmacology July 1991, 40 (1) 135-142;
  2. Fortin, R

    1. You have access
      5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;
  3. Fridland, A

    1. You have access
      Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
      N R Hartman, G S Ahluwalia, D A Cooney, H Mitsuya, S Kageyama, A Fridland, S Broder and D G Johns
      Molecular Pharmacology July 1991, 40 (1) 118-124;

G

  1. Gauthier, J Y

    1. You have access
      5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;
  2. Ged, C

    1. You have access
      Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.
      P K Srivastava, C H Yun, P H Beaune, C Ged and F P Guengerich
      Molecular Pharmacology July 1991, 40 (1) 69-79;
  3. Gerfen, C R

    1. You have access
      Cloning and expression of an A1 adenosine receptor from rat brain.
      L C Mahan, L D McVittie, E M Smyk-Randall, H Nakata, F J Monsma, C R Gerfen and D R Sibley
      Molecular Pharmacology July 1991, 40 (1) 1-7;
  4. Gonzalez, F J

    1. You have access
      Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6.
      R F Tyndale, R Sunahara, T Inaba, W Kalow, F J Gonzalez and H B Niznik
      Molecular Pharmacology July 1991, 40 (1) 63-68;
  5. Green, M

    1. You have access
      Purification and properties of a rat liver phenobarbital-inducible 4-hydroxybiphenyl UDP-glucuronosyltransferase.
      P Styczynski, M Green, J Puig, B Coffman and T Tephly
      Molecular Pharmacology July 1991, 40 (1) 80-84;
  6. Guengerich, F P

    1. You have access
      Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.
      P K Srivastava, C H Yun, P H Beaune, C Ged and F P Guengerich
      Molecular Pharmacology July 1991, 40 (1) 69-79;

H

  1. Hamano, S

    1. You have access
      Tetrodotoxin-insensitive Na+ channel activator palytoxin inhibits tyrosine uptake into cultured bovine adrenal chromaffin cells.
      K Morita, K Teraoka, M Azuma, M Oka and S Hamano
      Molecular Pharmacology July 1991, 40 (1) 112-117;
  2. Harden, T K

    1. You have access
      Solubilization of a guanine nucleotide-sensitive form of the P2Y-purinergic receptor.
      R A Jeffs, C L Cooper and T K Harden
      Molecular Pharmacology July 1991, 40 (1) 85-92;
  3. Hartman, N R

    1. You have access
      Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
      N R Hartman, G S Ahluwalia, D A Cooney, H Mitsuya, S Kageyama, A Fridland, S Broder and D G Johns
      Molecular Pharmacology July 1991, 40 (1) 118-124;
  4. Hibert, M F

    1. You have access
      Three-dimensional models of neurotransmitter G-binding protein-coupled receptors.
      M F Hibert, S Trumpp-Kallmeyer, A Bruinvels and J Hoflack
      Molecular Pharmacology July 1991, 40 (1) 8-15;
  5. Hoflack, J

    1. You have access
      Three-dimensional models of neurotransmitter G-binding protein-coupled receptors.
      M F Hibert, S Trumpp-Kallmeyer, A Bruinvels and J Hoflack
      Molecular Pharmacology July 1991, 40 (1) 8-15;
  6. Hosie, L

    1. You have access
      Purification, immunochemical characterization, and immunohistochemical localization of rat hepatic aryl sulfotransferase IV.
      M W Duffel, T P Binder, L Hosie, H A Baden, J A Sanders, S A Knapp and J Baron
      Molecular Pharmacology July 1991, 40 (1) 36-44;
  7. Hughes, J

    1. You have access
      Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography.
      V U Dissanayake, J Hughes and J C Hunter
      Molecular Pharmacology July 1991, 40 (1) 93-100;
  8. Hunter, J C

    1. You have access
      Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography.
      V U Dissanayake, J Hughes and J C Hunter
      Molecular Pharmacology July 1991, 40 (1) 93-100;

I

  1. Inaba, T

    1. You have access
      Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6.
      R F Tyndale, R Sunahara, T Inaba, W Kalow, F J Gonzalez and H B Niznik
      Molecular Pharmacology July 1991, 40 (1) 63-68;

J

  1. Jaiswal, N

    1. You have access
      Muscarinic receptor-mediated prostacyclin and cGMP synthesis in cultured vascular cells.
      N Jaiswal, R K Jaiswal and K U Malik
      Molecular Pharmacology July 1991, 40 (1) 101-106;
  2. Jaiswal, R K

    1. You have access
      Muscarinic receptor-mediated prostacyclin and cGMP synthesis in cultured vascular cells.
      N Jaiswal, R K Jaiswal and K U Malik
      Molecular Pharmacology July 1991, 40 (1) 101-106;
  3. Jeffs, R A

    1. You have access
      Solubilization of a guanine nucleotide-sensitive form of the P2Y-purinergic receptor.
      R A Jeffs, C L Cooper and T K Harden
      Molecular Pharmacology July 1991, 40 (1) 85-92;
  4. Johns, D G

    1. You have access
      Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
      N R Hartman, G S Ahluwalia, D A Cooney, H Mitsuya, S Kageyama, A Fridland, S Broder and D G Johns
      Molecular Pharmacology July 1991, 40 (1) 118-124;

K

  1. Kageyama, S

    1. You have access
      Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
      N R Hartman, G S Ahluwalia, D A Cooney, H Mitsuya, S Kageyama, A Fridland, S Broder and D G Johns
      Molecular Pharmacology July 1991, 40 (1) 118-124;
  2. Kalow, W

    1. You have access
      Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6.
      R F Tyndale, R Sunahara, T Inaba, W Kalow, F J Gonzalez and H B Niznik
      Molecular Pharmacology July 1991, 40 (1) 63-68;
  3. Kim, S G

    1. You have access
      Pyridine effects on expression and molecular regulation of the cytochrome P450IA gene subfamily.
      S G Kim, S L Reddy, J C States and R F Novak
      Molecular Pharmacology July 1991, 40 (1) 52-57;
  4. Knapp, S A

    1. You have access
      Purification, immunochemical characterization, and immunohistochemical localization of rat hepatic aryl sulfotransferase IV.
      M W Duffel, T P Binder, L Hosie, H A Baden, J A Sanders, S A Knapp and J Baron
      Molecular Pharmacology July 1991, 40 (1) 36-44;
  5. Kroemer, H K

    1. You have access
      Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanism.
      H K Kroemer, C Fischer, C O Meese and M Eichelbaum
      Molecular Pharmacology July 1991, 40 (1) 135-142;

L

  1. Lauriault, V V

    1. You have access
      Molecular mechanism for prevention of N-acetyl-p-benzoquinoneimine cytotoxicity by the permeable thiol drugs diethyldithiocarbamate and dithiothreitol.
      V V Lauriault and P J O'Brien
      Molecular Pharmacology July 1991, 40 (1) 125-134;
  2. Lévillé, C

    1. You have access
      5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;
  3. Li, M

    1. You have access
      Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors.
      M Li, R P Yasuda, S J Wall, A Wellstein and B B Wolfe
      Molecular Pharmacology July 1991, 40 (1) 28-35;

M

  1. MacIntyre, D E

    1. You have access
      5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;
  2. Mahan, L C

    1. You have access
      Cloning and expression of an A1 adenosine receptor from rat brain.
      L C Mahan, L D McVittie, E M Smyk-Randall, H Nakata, F J Monsma, C R Gerfen and D R Sibley
      Molecular Pharmacology July 1991, 40 (1) 1-7;
  3. Malik, K U

    1. You have access
      Muscarinic receptor-mediated prostacyclin and cGMP synthesis in cultured vascular cells.
      N Jaiswal, R K Jaiswal and K U Malik
      Molecular Pharmacology July 1991, 40 (1) 101-106;
  4. Mancini, J A

    1. You have access
      5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;
  5. McVittie, L D

    1. You have access
      Cloning and expression of an A1 adenosine receptor from rat brain.
      L C Mahan, L D McVittie, E M Smyk-Randall, H Nakata, F J Monsma, C R Gerfen and D R Sibley
      Molecular Pharmacology July 1991, 40 (1) 1-7;
  6. Meese, C O

    1. You have access
      Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanism.
      H K Kroemer, C Fischer, C O Meese and M Eichelbaum
      Molecular Pharmacology July 1991, 40 (1) 135-142;
  7. Mitsuya, H

    1. You have access
      Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
      N R Hartman, G S Ahluwalia, D A Cooney, H Mitsuya, S Kageyama, A Fridland, S Broder and D G Johns
      Molecular Pharmacology July 1991, 40 (1) 118-124;
  8. Monsma, F J

    1. You have access
      Cloning and expression of an A1 adenosine receptor from rat brain.
      L C Mahan, L D McVittie, E M Smyk-Randall, H Nakata, F J Monsma, C R Gerfen and D R Sibley
      Molecular Pharmacology July 1991, 40 (1) 1-7;
  9. Morita, K

    1. You have access
      Tetrodotoxin-insensitive Na+ channel activator palytoxin inhibits tyrosine uptake into cultured bovine adrenal chromaffin cells.
      K Morita, K Teraoka, M Azuma, M Oka and S Hamano
      Molecular Pharmacology July 1991, 40 (1) 112-117;

N

  1. Nakata, H

    1. You have access
      Cloning and expression of an A1 adenosine receptor from rat brain.
      L C Mahan, L D McVittie, E M Smyk-Randall, H Nakata, F J Monsma, C R Gerfen and D R Sibley
      Molecular Pharmacology July 1991, 40 (1) 1-7;
  2. Nickolson, V J

    1. You have access
      Novel receptor site involved in enhancement of stimulus-induced acetylcholine, dopamine, and serotonin release.
      S W Tam, D Rominger and V J Nickolson
      Molecular Pharmacology July 1991, 40 (1) 16-21;
  3. Niznik, H B

    1. You have access
      Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6.
      R F Tyndale, R Sunahara, T Inaba, W Kalow, F J Gonzalez and H B Niznik
      Molecular Pharmacology July 1991, 40 (1) 63-68;
  4. Novak, R F

    1. You have access
      Pyridine effects on expression and molecular regulation of the cytochrome P450IA gene subfamily.
      S G Kim, S L Reddy, J C States and R F Novak
      Molecular Pharmacology July 1991, 40 (1) 52-57;

O

  1. O'Brien, P J

    1. You have access
      Molecular mechanism for prevention of N-acetyl-p-benzoquinoneimine cytotoxicity by the permeable thiol drugs diethyldithiocarbamate and dithiothreitol.
      V V Lauriault and P J O'Brien
      Molecular Pharmacology July 1991, 40 (1) 125-134;
  2. Oka, M

    1. You have access
      Tetrodotoxin-insensitive Na+ channel activator palytoxin inhibits tyrosine uptake into cultured bovine adrenal chromaffin cells.
      K Morita, K Teraoka, M Azuma, M Oka and S Hamano
      Molecular Pharmacology July 1991, 40 (1) 112-117;

P

  1. Pachter, J A

    1. You have access
      Noncompetitive inhibition of inositol monophosphatase by K-76 monocarboxylic acid.
      J A Pachter
      Molecular Pharmacology July 1991, 40 (1) 107-111;
  2. Peng, H M

    1. You have access
      Differences in the developmental expression of rabbit cytochromes P-450 2E1 and 2E2.
      H M Peng, T D Porter, X X Ding and M J Coon
      Molecular Pharmacology July 1991, 40 (1) 58-62;
  3. Porter, T D

    1. You have access
      Differences in the developmental expression of rabbit cytochromes P-450 2E1 and 2E2.
      H M Peng, T D Porter, X X Ding and M J Coon
      Molecular Pharmacology July 1991, 40 (1) 58-62;
  4. Prasit, P

    1. You have access
      5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;
  5. Puig, J

    1. You have access
      Purification and properties of a rat liver phenobarbital-inducible 4-hydroxybiphenyl UDP-glucuronosyltransferase.
      P Styczynski, M Green, J Puig, B Coffman and T Tephly
      Molecular Pharmacology July 1991, 40 (1) 80-84;

R

  1. Reddy, S L

    1. You have access
      Pyridine effects on expression and molecular regulation of the cytochrome P450IA gene subfamily.
      S G Kim, S L Reddy, J C States and R F Novak
      Molecular Pharmacology July 1991, 40 (1) 52-57;
  2. Rominger, D

    1. You have access
      Novel receptor site involved in enhancement of stimulus-induced acetylcholine, dopamine, and serotonin release.
      S W Tam, D Rominger and V J Nickolson
      Molecular Pharmacology July 1991, 40 (1) 16-21;

S

  1. Sanders, J A

    1. You have access
      Purification, immunochemical characterization, and immunohistochemical localization of rat hepatic aryl sulfotransferase IV.
      M W Duffel, T P Binder, L Hosie, H A Baden, J A Sanders, S A Knapp and J Baron
      Molecular Pharmacology July 1991, 40 (1) 36-44;
  2. Sibley, D R

    1. You have access
      Cloning and expression of an A1 adenosine receptor from rat brain.
      L C Mahan, L D McVittie, E M Smyk-Randall, H Nakata, F J Monsma, C R Gerfen and D R Sibley
      Molecular Pharmacology July 1991, 40 (1) 1-7;
  3. Smyk-Randall, E M

    1. You have access
      Cloning and expression of an A1 adenosine receptor from rat brain.
      L C Mahan, L D McVittie, E M Smyk-Randall, H Nakata, F J Monsma, C R Gerfen and D R Sibley
      Molecular Pharmacology July 1991, 40 (1) 1-7;
  4. Srivastava, P K

    1. You have access
      Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.
      P K Srivastava, C H Yun, P H Beaune, C Ged and F P Guengerich
      Molecular Pharmacology July 1991, 40 (1) 69-79;
  5. States, J C

    1. You have access
      Pyridine effects on expression and molecular regulation of the cytochrome P450IA gene subfamily.
      S G Kim, S L Reddy, J C States and R F Novak
      Molecular Pharmacology July 1991, 40 (1) 52-57;
  6. Styczynski, P

    1. You have access
      Purification and properties of a rat liver phenobarbital-inducible 4-hydroxybiphenyl UDP-glucuronosyltransferase.
      P Styczynski, M Green, J Puig, B Coffman and T Tephly
      Molecular Pharmacology July 1991, 40 (1) 80-84;
  7. Sunahara, R

    1. You have access
      Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6.
      R F Tyndale, R Sunahara, T Inaba, W Kalow, F J Gonzalez and H B Niznik
      Molecular Pharmacology July 1991, 40 (1) 63-68;

T

  1. Tam, S W

    1. You have access
      Novel receptor site involved in enhancement of stimulus-induced acetylcholine, dopamine, and serotonin release.
      S W Tam, D Rominger and V J Nickolson
      Molecular Pharmacology July 1991, 40 (1) 16-21;
  2. Tephly, T

    1. You have access
      Purification and properties of a rat liver phenobarbital-inducible 4-hydroxybiphenyl UDP-glucuronosyltransferase.
      P Styczynski, M Green, J Puig, B Coffman and T Tephly
      Molecular Pharmacology July 1991, 40 (1) 80-84;
  3. Teraoka, K

    1. You have access
      Tetrodotoxin-insensitive Na+ channel activator palytoxin inhibits tyrosine uptake into cultured bovine adrenal chromaffin cells.
      K Morita, K Teraoka, M Azuma, M Oka and S Hamano
      Molecular Pharmacology July 1991, 40 (1) 112-117;
  4. Thérien, M

    1. You have access
      5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;
  5. Thio, L L

    1. You have access
      Effects of bromowillardiine and willardiine on non-N-methyl-D-aspartate receptors in postnatal rat hippocampal neurons.
      C F Zorumski, L L Thio and D B Clifford
      Molecular Pharmacology July 1991, 40 (1) 45-51;
  6. Trumpp-Kallmeyer, S

    1. You have access
      Three-dimensional models of neurotransmitter G-binding protein-coupled receptors.
      M F Hibert, S Trumpp-Kallmeyer, A Bruinvels and J Hoflack
      Molecular Pharmacology July 1991, 40 (1) 8-15;
  7. Tyndale, R F

    1. You have access
      Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6.
      R F Tyndale, R Sunahara, T Inaba, W Kalow, F J Gonzalez and H B Niznik
      Molecular Pharmacology July 1991, 40 (1) 63-68;

W

  1. Wall, S J

    1. You have access
      Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors.
      M Li, R P Yasuda, S J Wall, A Wellstein and B B Wolfe
      Molecular Pharmacology July 1991, 40 (1) 28-35;
  2. Wellstein, A

    1. You have access
      Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors.
      M Li, R P Yasuda, S J Wall, A Wellstein and B B Wolfe
      Molecular Pharmacology July 1991, 40 (1) 28-35;
  3. Wolfe, B B

    1. You have access
      Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors.
      M Li, R P Yasuda, S J Wall, A Wellstein and B B Wolfe
      Molecular Pharmacology July 1991, 40 (1) 28-35;

Y

  1. Yasuda, R P

    1. You have access
      Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors.
      M Li, R P Yasuda, S J Wall, A Wellstein and B B Wolfe
      Molecular Pharmacology July 1991, 40 (1) 28-35;
  2. Yun, C H

    1. You have access
      Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.
      P K Srivastava, C H Yun, P H Beaune, C Ged and F P Guengerich
      Molecular Pharmacology July 1991, 40 (1) 69-79;

Z

  1. Zamboni, R

    1. You have access
      5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;
  2. Zorumski, C F

    1. You have access
      Effects of bromowillardiine and willardiine on non-N-methyl-D-aspartate receptors in postnatal rat hippocampal neurons.
      C F Zorumski, L L Thio and D B Clifford
      Molecular Pharmacology July 1991, 40 (1) 45-51;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 40, Issue 1
1 Jul 1991
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics